Article Details

Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections

Retrieved on: 2018-10-21 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections. View article details on hiswai:

Excerpt

<div><b>New Enterprise Associates</b> led the Series A round. Qpex is led by Michael Dudley, the former chief scientific officer of The Medicines Company.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up